Fidelity Covington Trust - Fidelity Quality Factor ETF
FQAL
Get informed when a big investor buys or sells
+ FollowShare Statistics
| Market cap | $26.06 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.91 (1.13%) |
| Earnings per Share | $- |
| Beta | 0.9 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 83.84%▲ 7.36% |
|---|---|
| Total Invested | $990.80M▲ 11.22% |
| Investors Holding | 149▲ 5.00% |
ESG Score
No data
About Fidelity Covington Trust
Relevant Senate Committees
Plays a critical role in shaping and scoring tax legislation, directly influencing corporate tax structures, capital investment, and the overall tax burden on the ETF's underlying companies.
Controls taxation, trade, and entitlement spending, directly impacting corporate valuations through tax policy and influencing major sectors like healthcare and retail.
Directly regulates the pharmaceutical/biotech sectors (drug approval) and influences labor costs through minimum wage and union laws, affecting profitability across many industries.
Crucial for antitrust enforcement and intellectual property law, directly impacting M&A activity and the competitive landscape for many large 'quality' companies, especially in tech.
Directly regulates the entire financial system (banks, SEC, crypto) and real estate, sectors that are fundamental to the economy and likely contain major 'quality' companies.
Exercises broad regulatory power over major sectors such as 'Big Tech,' aerospace, and telecommunications, where many large 'quality' companies are likely to be found.